TD Asset Management Inc

Position in WVE — Wave Life Sciences, Inc.

CIK 1056053 Toronto, A6

Position in WVE

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,127,291

-$1,329,197 QoQ

Shares Held

194,026

-42.7% QoQ

Ownership

0.098%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 238 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. WVE ranks #95 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,127,291	194,026	-42.7%	Shares	Sole	2026-08-04
2026-03-31	$2,456,488	338,826	+34.4%	Shares	Sole	2026-05-11
2025-12-31	$4,286,720	252,160	+77.1%	Shares	Sole	2026-02-10
2025-09-30	$1,042,426	142,408	-20.7%	Shares	Sole	2025-11-10
2025-06-30	$1,167,452	179,608	+16.3%	Shares	Sole	2025-07-28
2025-03-31	$1,247,616	154,408	-51.2%	Shares	Sole	2025-05-07
2024-12-31	$3,911,468	316,206	+25.6%	Shares	Sole	2025-02-11
2024-09-30	$2,064,809	251,806	+36.9%	Shares	Sole	2024-11-01
2024-06-30	$917,890	183,946	-27.0%	Shares	Sole	2024-08-02
2024-03-31	$1,554,506	251,946	+22.5%	Shares	Sole	2024-05-08
2023-12-31	$1,039,017	205,746	+26.5%	Shares	Sole	2024-02-12
2023-09-30	$935,479	162,692	+217.5%	Shares	Sole	2023-10-27
2020-12-31	$403,211	51,234	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.